Better Patient Outcomes with Epic Language Access Integration
Learn how to improve health outcomes and ensure compliance for individuals with Limited English Proficiency (LEP) with direct language access integration to the Epic Electronic Health Record (EHR) system.
Case Study: Multilingual Retail Marketing
New AI Content Creation Solutions for a Sports and Apparel Giant
Human Insight, Augmented by AI
Lionbridge Aurora AI™ is our approach to AI: guided by human insight and built into every solution we deliver. Our experts apply AI to scale your multilingual content and reach new audiences with culturally relevant, hyper-personalized experiences.
Evaluate Translation Quality Through Controlled Pilot
Measure Total Economics of Translation
Connect Translation Performance to Commercial Readiness and Buyer Experience
Safely Implement AI into Workflows
Staying competitive in today’s medical device market means reducing time-to-market and clinical trial costs — without sacrificing compliance with medical device regulations. Lowering your medical device translation spend or speeding up life sciences localization is useless if your language quality is compromised or regulatory approval is jeopardized. This blog explores four approaches your competitors are taking to medical device localization to cut costs, shorten turnaround times, and get their devices to global markets faster. Our medical device translation services experts share four approaches we’re seeing global manufacturing giants use to help them dominate markets right now.
Evaluating your medical device translation is critical to reaching approval. Many of our successful life sciences language services customers are using controlled pilots to ensure their translation workflows perform optimally. We run a controlled pilot to compare representative content under the customer’s current or proposed workflows.
Before testing, we define our acceptance criteria, including:
After the pilot, we evaluate results by language and content type. This approach is more comprehensive than just pulling an aggregate score. Lastly, this pilot is accompanied by both a change management and training plan. These measures ensure all stakeholders are kept informed and are ready to execute the new processes after the pilot is concluded.
Some medical device manufacturers divide their medical device translation services among many life sciences translation services providers, missing out on the savings of consolidating to a select set of preferred vendors. When manufacturers work with just two or three vendors, they can benefit from such efficiencies as translation memory savings and volume discounts. These occur over a series of projects, not just one. Beyond translation memory savings, vendor consolidation can optimize other language strategy costs related to:
Another, more accurate way to evaluate the total spend for language budget is to compare vendors by non-commercial measures, such as:
These factors in an overall program seriously impact language spend and timelines more than a deep discount on one project.
Lastly, consider AI productivity gains. Powerful AI-enhanced workflows will deliver priceless multiplying benefits for medical device manufacturers now and into the future.
To stay competitive, manufacturers should work with providers who implement AI into their workflows safely and responsibly, reducing turnaround time by 50% (or more).
To get the most effective medical device translation, evaluate it by how it affects commercial readiness and buyer experience. Measure translation turnaround times, not just for your translation partners, but also for the buyer and reviewer processes. Consider these KPIs:
Another tactic is to use a balanced scorecard with topics like:
Lastly, address these items as part of implementation:
Use a phased approach for these steps, going from baseline, to pilot, to evaluation, to scale, to monitoring.
Using AI-powered translation for life sciences is vital to staying competitive in medical device markets worldwide. Getting to market faster than your competitors isn’t simple, but safely implementing AI in your medical device translation workflows is key. While life sciences localization has initially shied away from AI usage due to risk and compliance concerns, industry giants are now embracing it.
Depending on the content, AI-enhanced workflows can be 50 or even 60% faster than traditional life sciences translation.
Keep up with competitors as you race to device approval and the markets by partnering with providers like Lionbridge. We have years of AI and medical device experience, and we understand how to implement it compliantly in workflows.
How will you get to market faster this year? How will you ensure more efficient spend on your medical device translation? Lionbridge can help you strategize and share tactics medical device giants use worldwide to win in their target markets. Let’s get in touch.